On Monday, Biohaven Ltd (NYSE: BHVN) opened lower -8.39% from the last session, before settling in for the closing price of $10.84. Price fluctuations for BHVN have ranged from $7.48 to $44.28 over the past 52 weeks.
Annual sales at Healthcare sector company slipped by -49.78% over the past five years. Company’s average yearly earnings per share was noted 29.02% at the time writing. With a float of $111.06 million, this company’s outstanding shares have now reached $132.69 million.
Biohaven Ltd (BHVN) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Biohaven Ltd is 16.30%, while institutional ownership is 65.40%. The most recent insider transaction that took place on Nov 17 ’25, was worth 144,770. In this transaction VP, Chief Accounting Officer of this company bought 17,000 shares at a rate of $8.52, taking the stock ownership to the 20,000 shares. Before that another transaction happened on Nov 13 ’25, when Company’s Director bought 400,000 for $7.50, making the entire transaction worth $3,000,000. This insider now owns 2,020,071 shares in total.
Biohaven Ltd (BHVN) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -1.71 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -1.47) by -0.24. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.96 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 29.02% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 38.08% during the next five years compared to -49.78% drop over the previous five years of trading.
Biohaven Ltd (NYSE: BHVN) Trading Performance Indicators
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -7.60, a number that is poised to hit -1.18 in the next quarter and is forecasted to reach -3.09 in one year’s time.
Technical Analysis of Biohaven Ltd (BHVN)
Biohaven Ltd (NYSE: BHVN) saw its 5-day average volume 3.07 million, a negative change from its year-to-date volume of 3.16 million. As of the previous 9 days, the stock’s Stochastic %D was 53.03%.
During the past 100 days, Biohaven Ltd’s (BHVN) raw stochastic average was set at 22.10%, which indicates a significant increase from 17.99% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.79 in the past 14 days, which was lower than the 0.93 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.09, while its 200-day Moving Average is $15.38. Nevertheless, the first resistance level for the watch stands at $10.69 in the near term. At $11.45, the stock is likely to face the second major resistance level. The third major resistance level sits at $12.01. If the price goes on to break the first support level at $9.37, it is likely to go to the next support level at $8.81. Assuming the price breaks the second support level, the third support level stands at $8.05.
Biohaven Ltd (NYSE: BHVN) Key Stats
There are currently 105,855K shares outstanding in the company with a market cap of 1.32 billion. Presently, the company’s annual sales total 0 K according to its annual income of -846,420 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -173,440 K.
